The increased risk for thromboembolism pre-cystectomy in patients undergoing neoadjuvant chemotherapy for muscle-invasive urinary bladder cancer is mainly due to central venous access: a multicenter evaluation

被引：0
|
作者：
Kristoffer Ottosson
Sofia Pelander
Markus Johansson
Ylva Huge
Firas Aljabery
Amir Sherif
机构：
[1] Umeå University,Department of Surgical and Perioperative Sciences, Urology and Andrology
[2] Linköping University,Division of Urology, Department of Clinical and Experimental Medicine
[3] Sundsvall Hospital,Department of Urology
来源：
International Urology and Nephrology | 2020年 / 52卷
关键词：
Complications; Cystectomy; Neoadjuvant therapy; Thromboembolism; Urinary bladder neoplasms;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：661 / 669
页数：8
相关论文
共 50 条
  • [41] The prognostic value of the neutrophil-to-lymphocyte ratio in patients with muscle-invasive bladder cancer treated with neoadjuvant chemotherapy and radical cystectomy
    Black, Anna J.
    Zargar, Homayoun
    Zargar-Shoshtari, Kamran
    Fairey, Adrian S.
    Mertens, Laura S.
    Dinney, Colin P.
    Mir, Maria C.
    Krabbe, Laura-Maria
    Cookson, Michael S.
    Jacobsen, Niels-Erik
    Griffin, Joshua
    Montgomery, Jeffrey S.
    Vasdev, Nikhil
    Yu, Evan Y.
    Xylinas, Evanguelos
    Campain, Nicholas J.
    Kassouf, Wassim
    Dall'Era, Marc A.
    Seah, Jo-An
    Ercole, Cesar E.
    Horenblas, Simon
    McGrath, John S.
    Aning, Jonathan
    Shariat, Shahrokh F.
    Wright, Jonathan L.
    Thorpe, Andrew C.
    Morgan, Todd M.
    Holzbeierlein, Jeff M.
    Bivalacqua, Trinity J.
    North, Scott
    Barocas, Daniel A.
    Lotan, Yair
    Grivas, Petros
    Stephenson, Andrew J.
    Shah, Jay B.
    van Rhijn, Bas W.
    Spiess, Philippe E.
    Daneshmand, Siamak
    Sridhar, Srikala S.
    Black, Peter C.
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2020, 38 (01) : 3.e17 - 3.e27
  • [42] IDENTIFICATION OF MOLECULAR BIOMARKERS OF CISPLATIN-BASED CHEMOSENSITIVITY IN PATIENTS UNDERGOING NEOADJUVANT CHEMOTHERAPY FOR MUSCLE-INVASIVE BLADDER CANCER
    Shah, Paras
    Kozel, Zachary
    Lee, Annette
    Korsunsky, Ilya
    Shih, Andrew
    Yaskiv, Oksana
    Vira, Manish
    Bradley, Thomas
    Zhu, Xinhua
    JOURNAL OF UROLOGY, 2017, 197 (04): : E1196 - E1197
  • [43] NEOADJUVANT CHEMOTHERAPY IS NOT ASSOCIATED WITH WORSE SHORT-TERM OUTCOMES IN PATIENTS WITH MUSCLE-INVASIVE BLADDER CANCER UNDERGOING RADICAL CYSTECTOMY: A POPULATION-BASED STUDY
    Gandaglia, Giorgio
    Popa, Ioana
    Abdollah, Firas
    Schiffmann, Jonas
    Azizi, Mounsif
    Trudeau, Vincent
    Hanna, Nawar
    Tian, Zhe
    Perrotte, Paul
    Quoc-Dien Trinh
    Montorsi, Francesco
    Briganti, Alberto
    Karakiewicz, Pierre I.
    Sun, Maxine
    JOURNAL OF UROLOGY, 2014, 191 (04): : E685 - E685
  • [44] ACCESS TO CARE PREDICTS ADEQUATE PELVIC LYMPH NODE DISSECTION IN PATIENTS UNDERGOING RADICAL CYSTECTOMY FOR MUSCLE-INVASIVE BLADDER CANCER
    Stimson, C. J.
    Patel, Sanjay G.
    Zaid, Harras B.
    Kaffenberger, Samuel D.
    Resnick, Matthew J.
    Barocas, Daniel A.
    Cookson, Michael S.
    Chang, Sam S.
    JOURNAL OF UROLOGY, 2013, 189 (04): : E665 - E666
  • [45] Prediction of pathological response following neoadjuvant chemotherapy in patients with muscle-invasive bladder cancer: the PRE-PREVENCYS trial
    Hinsenveld, F. J.
    Noordman, B. J.
    Boormans, J. L.
    Voortman, J.
    van Leenders, G. J. L. H.
    van der Pas, S. L.
    van Beek, S. C.
    Oprea-Lager, D. E.
    Vis, A. N.
    BMC CANCER, 2021, 21 (01)
  • [46] Prediction of pathological response following neoadjuvant chemotherapy in patients with muscle-invasive bladder cancer: the PRE-PREVENCYS trial
    F. J. Hinsenveld
    B. J. Noordman
    J. L. Boormans
    J. Voortman
    G. J. L. H. van Leenders
    S. L. van der Pas
    S. C. van Beek
    D. E. Oprea-Lager
    A. N. Vis
    BMC Cancer, 21
  • [47] SURVIVAL OF PATIENTS WITH MUSCLE-INVASIVE UROTHELIAL CANCER OF THE BLADDER WITH RESIDUAL DISEASE AT THE TIME OF CYSTECTOMY FOLLOWING NEOADJUVANT CHEMOTHERAPY: AN ANALYSIS OF THE NATIONAL CANCER DATABASE
    Pfail, John L.
    Martini, Alberto
    Tomer, Nir
    Audenet, Francois
    Daza, Jorge
    Charap, Andrew
    Attalla, Kyrollis
    Waingankar, Nikhil
    Wiklund, Peter
    Galsky, Matthew D.
    Sfakianos, John P.
    JOURNAL OF UROLOGY, 2020, 203 : E839 - E839
  • [48] CHEMOTHERAPY VS IMMUNOTHERAPY AS NEOADJUVANT THERAPIES IN CISPLATIN-ELIGIBLE PATIENTS UNDERGOING RADICAL CYSTECTOMY FOR MUSCLE INVASIVE BLADDER CANCER
    Nocera, Luigi
    Bandini, Marco
    Basile, Giuseppe
    Moschini, Marco
    Naidu, Shreyas
    Rose, Kyle
    Li, Roger
    Spiess, Philippe
    Necchi, Andrea
    JOURNAL OF UROLOGY, 2023, 209 : E1126 - E1127
  • [49] Meta-analysis of neoadjuvant chemotherapy compared to radical cystectomy alone in improving overall survival of muscle-invasive bladder cancer patients
    Agus Rizal A. H. Hamid
    Fanny Riana Ridwan
    Dyandra Parikesit
    Fina Widia
    Chaidir Arif Mochtar
    Rainy Umbas
    BMC Urology, 20
  • [50] PARTIAL VS. COMPLETE RESPONSE TO NEOADJUVANT CHEMOTHERAPY IN MUSCLE-INVASIVE BLADDER CANCER PATIENTS: A COMPARISON OF POST-CYSTECTOMY OUTCOMES
    Brant, Aaron
    Kates, Max
    Chappidi, Meera
    Patel, Hiten
    Sopko, Nikolai
    Bivalacqua, Trinity
    JOURNAL OF UROLOGY, 2016, 195 (04): : E768 - E768
12345